Treatment of patients with arterial hypertension and metabolic syndrome. The role of the combination drugs

被引：0
|
作者：
Shilov, A. M. [1 ]
Dulaeva, M. S. [1 ]
Osia, A. O. [1 ]
Lishuta, A. S. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Trubetskaya Ul 8-2, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2014年 / 10卷 / 01期
关键词：
arterial hypertension; combination therapy; fixed-dose drug combination; enalapril; lercanidipine;
D O I：
10.20996/1819-6446-2014-10-1-92-98
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Data about the current approach to the choice of dual antihypertensive combinations in various clinical situations for treatment of hypertension are presented. Advantages and indications for the combination of an ACE inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from prospective studies on the efficacy and safety of combination of third generation calcium channel blocker lercanidipine with ACE inhibitor enalapril are presented.
引用
收藏
页码：92 / 98
页数：7
相关论文
共 50 条
  • [21] ABSOLUTE RISK (SCORE 2005) IN OUTWARD-PATIENTS WITH ARTERIAL HYPERTENSION AND WITH/WITHOUT METABOLIC SYNDROME. INTERGENDER DIFFERENCES
    Kosmalova, V.
    Polak, M.
    Turek, P.
    Lietava, J.
    JOURNAL OF HYPERTENSION, 2010, 28 : E572 - E572
  • [22] Role of arterial hypertension in the development of global risk of metabolic syndrome
    Mamedov, MN
    JOURNAL OF HYPERTENSION, 2004, 22 : S368 - S369
  • [23] Comparative studies of different combination of antihypertensive drugs in the treatment of arterial hypertension
    Khalid, Shah
    Ali, Irfan
    Malik, Muhammad Rehan
    Farooqui, Mehjabeen
    Atif, Muhammad
    Niazi, Zahid Rasul
    Khan, Kamran Ahmad
    Hamid, Ali Mohmedahmed Mahmoud
    Umair, Muhammad
    Azam, Aamina
    Rehman, Parsa
    Shah, Syed Hussain
    BIOSCIENCE RESEARCH, 2023, 20 (02): : 409 - 414
  • [24] Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
    Trusov, V. V.
    Aksenov, K. V.
    Chernyshova, T. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (04): : 13 - 19
  • [25] The role of β-blockers in patients with metabolic syndrome and hypertension
    Andras, Dezsi Csaba
    ORVOSI HETILAP, 2015, 156 (16) : 623 - 625
  • [26] Efficacy of the Combination of Lisinopril and Hydrochlorothiazide in Patients with Hypertension and Metabolic Syndrome Uncontrolled with Previous Treatment
    Stolyarova, N. I.
    Li, E. D.
    Boriskina, T. V.
    AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 : 13 - 13
  • [27] Parameters of high-density lipoproteins in patients with arterial hypertension in combination with other components of metabolic syndrome
    I. N. Ozerova
    N. V. Perova
    N. V. Shchel’tsyna
    M. N. Mamedov
    Bulletin of Experimental Biology and Medicine, 2007, 143 : 320 - 322
  • [28] Parameters of high-density lipoproteins in patients with arterial hypertension in combination with other components of metabolic syndrome
    Ozerova, I. N.
    Perova, N. V.
    Shchel'tsyna, N. V.
    Mamedov, M. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 143 (03) : 320 - 322
  • [29] Value of fixed combination of verapamil CP/trandolapril in the treatment of patients with metabolic syndrome. Results of the STAR trial
    Kobalava, Zh. D.
    Kotovskaya, Yu. V.
    KARDIOLOGIYA, 2007, 47 (09) : 74 - 78
  • [30] Features of Treatment of Hypertension in Patients With Metabolic Syndrome
    Shilov, A. M.
    Melnik, M. V.
    Dulaeva, M. S.
    Eremina, I. V.
    KARDIOLOGIYA, 2011, 51 (12) : 84 - 89
12345